Nathaniel Roquet
About Nathaniel Roquet
Nathaniel Roquet is the Director of the Reagent Foundry at Tessera Therapeutics, where he has worked since 2022. He has a background in computational biology and biophysics, having held positions at Catalog Technologies Inc, Tessera Therapeutics, Harvard University, and Princeton University.
Current Role at Tessera Therapeutics
Nathaniel Roquet serves as the Director of the Reagent Foundry at Tessera Therapeutics. He has held this position since 2022, contributing to the company's focus on innovative therapeutic solutions. His role involves overseeing the development and production of reagents that are essential for the company's research and development initiatives.
Previous Experience at Tessera Therapeutics
Before becoming the Director of the Reagent Foundry, Nathaniel Roquet worked as the Lead Scientist in Computational Biology at Tessera Therapeutics from 2020 to 2022. In this position, he focused on leveraging computational methods to advance the understanding of biological systems and enhance therapeutic development.
Experience at Catalog Technologies Inc
Nathaniel Roquet co-founded Catalog Technologies Inc, where he served as the Chief Technology and Innovation Officer (CTIO) from 2016 to 2020. During his tenure, he played a pivotal role in developing technology solutions aimed at improving the efficiency and effectiveness of scientific research.
Academic Background
Nathaniel Roquet earned his Doctor of Philosophy (PhD) in Biophysics from Harvard University, where he studied from 2011 to 2017. Prior to that, he completed his Bachelor of Arts (B.A.) in Physics at Princeton University from 2007 to 2011. His academic training provided a strong foundation in both theoretical and experimental aspects of science.
Research Experience
Throughout his academic career, Nathaniel Roquet gained significant research experience. He worked as a Graduate Researcher at Harvard University from 2011 to 2016, focusing on advanced topics in biophysics. Additionally, he was an Undergraduate Researcher at Princeton University from 2008 to 2011, contributing to projects in the Rabinowitz Lab at the Lewis-Sigler Institute for Integrative Genomics.